A Comparison of Macular Translocation with Patch Graft in Neovascular Age-Related Macular Degeneration

Abstract

In the present cohort, MT maintained VA for 3 years but PG did not. This outcome may be related to the differences in surgical approach, source of RPE, and choroidal perfusion. The authors recommend MT in preference to PG for treatment of patients with the second eye affected by neovascular AMD unsuitable for other treatment.